Where is the live CopyMark page for USPTO serial 74250016?

The live record is at https://getcopymark.com/trademark/74250016. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns BIOCHEM PHARMA?

According to the public USPTO record for serial number 74250016, the listed owner(s) include: BIOCHEM PHARMA INC..

What is USPTO serial number 74250016?

Serial number 74250016 is the USPTO application identifier for the mark BIOCHEM PHARMA. It is used to track examination, publication, and registration of this trademark.

What is the current status of BIOCHEM PHARMA?

BIOCHEM PHARMA (74250016) currently shows USPTO status code 601 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Which trademark classes cover BIOCHEM PHARMA?

The public record lists International Classes: 005. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: BIOCHEM PHARMA Serial# 74250016 | status 601; last event ABN1 | Trademark Info & Attorney Guidance

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BIOCHEM PHARMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

BIOCHEM PHARMA INC.
Laval, Quebec, CA
Other trademarks owned by BIOCHEM PHARMA INC.

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lawrence E. Abelman

LAWRENCE E ABELMAN C/O ABELMAN FRAYNE & SCHWAB708 THIRD AVENEW YORK, NY 10017-4141UNITED STATES

Goods and services

Class	Description	Status	First use
005	pharmaceutical preparations used to treat aids, viral infections, cancer, cardiovascular problems, cholesterol; analgesics; kits consisting primarily of reagents used for the diagnosis of aids; vaccines and immunological preparations use to prevent infectious diseases	ABANDONED	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Jan 12, 1995	ABN1	ABANDONMENT - EXPRESS MAILED	—
Dec 7, 1994	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Aug 11, 1994	CNSI	INQUIRY AS TO SUSPENSION MAILED	—
Nov 19, 1993	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Oct 18, 1993	UNPR	UNRESPONSIVE/DUPLICATE PAPER RECEIVED	—
Sep 13, 1993	CNSL	LETTER OF SUSPENSION MAILED	—
Aug 23, 1993	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Jul 9, 1993	CNSI	INQUIRY AS TO SUSPENSION MAILED	—
Jan 5, 1993	CNSL	LETTER OF SUSPENSION MAILED	—
Nov 18, 1992	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
May 18, 1992	CNRT	NON-FINAL ACTION MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 29, 1992	DOCK	ASSIGNED TO EXAMINER	—

BIOCHEM PHARMA